ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

PSTX Poseida Therapeutics Inc

2.74
0.32 (13.22%)
02 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Poseida Therapeutics Inc PSTX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.32 13.22% 2.74 08:31:32
Open Price Low Price High Price Close Price Previous Close
2.69 2.685 3.00 2.77 2.42
more quote information »

Recent News

Date Time Source Heading
02/5/202411:30PRNUSAstellas and Poseida Therapeutics Enter Into Research..
02/5/202405:25APSBiotech Soars on Research Collaboration And License..
01/5/202423:00PRNUSAstellas and Poseida Therapeutics Enter Into Research..
18/4/202422:00PRNUSPoseida Therapeutics Announces Strong Lineup of..
17/4/202423:00PRNUSPoseida Therapeutics Hosts Gene Therapy R&D Day Highlighting..
09/4/202402:00PRNUSPoseida Therapeutics Presents New Phase 1 Data at AACR 2024..
02/4/202407:05PRNUSPoseida Therapeutics Announces Inducement Grant Under Nasdaq..
26/3/202407:05PRNUSPoseida Therapeutics Appoints Syed Rizvi, M.D., as Chief..
20/3/202407:05PRNUSPoseida Therapeutics to Present at H.C. Wainwright 2nd..
14/3/202407:05PRNUSPoseida Therapeutics Announces FDA Orphan Drug Designation..
08/3/202408:07PRNUSPoseida Therapeutics Provides Updates and Financial Results..
08/3/202408:05EDGAR2Form 8-K - Current report
05/3/202409:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202409:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202408:05PRNUSPoseida Therapeutics Announces Inducement Grant Under Nasdaq..
09/2/202408:10EDGAR2Form S-8 - Securities to be offered to employees in employee..
05/1/202408:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202408:01EDGAR2Form 8-K - Current report
05/1/202400:00PRNUSPoseida Therapeutics Highlights Recent Progress, Strategic..
12/12/202302:31DJNPoseida Therapeutics Shares Climb on Positive Data for Blood..
11/12/202322:06EDGAR2Form 8-K - Current report
11/12/202304:00PRNUSPoseida Therapeutics Presents Positive Early Results from..
10/11/202308:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/11/202308:05EDGAR2Form 8-K - Current report
10/11/202308:05PRNUSPoseida Therapeutics Provides Updates and Financial Results..
08/11/202300:00PRNUSPoseida Therapeutics to Present at Two Upcoming Investor..
03/11/202300:01PRNUSPoseida Therapeutics to Present at the 65th ASH Annual..
10/10/202307:30PRNUSPoseida Therapeutics Announces Leadership Transition
05/9/202322:00PRNUSPoseida Therapeutics to Present at Two Upcoming Investor..
15/8/202306:41EDGAR2Form SC 13D - General statement of acquisition of beneficial..
12/8/202306:48EDGAR2Form D - Notice of Exempt Offering of Securities
09/8/202306:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202306:06EDGAR2Form 8-K - Current report
09/8/202306:05PRNUSPoseida Therapeutics Provides Financial Results for the..
08/8/202300:41DJNPoseida Therapeutics Shares Leap on Astellas Investments
07/8/202323:58DJNPoseida Therapeutics in $50 Million Investment Deal With..
07/8/202323:01EDGAR2Form 8-K - Current report
07/8/202323:01PRNUSPoseida Therapeutics Announces Strategic Investment by..
07/8/202323:00PRNUSAstellas and Poseida Therapeutics Announce Strategic..
05/7/202322:00PRNUSPoseida Therapeutics Announces FDA Clearance of..
26/6/202322:00PRNUSPoseida Therapeutics to Join Russell 3000® and Russell 2000®..
01/6/202322:00PRNUSPoseida Therapeutics Announces Virtual 2023 Annual Meeting..
23/5/202322:00PRNUSPoseida Therapeutics to Present at Stifel 2023 Tailoring..
22/5/202322:00PRNUSPoseida Therapeutics to Present at 31st Congress of the..
18/5/202322:00PRNUSPoseida Therapeutics Presents Encouraging Preclinical Data..
10/5/202306:05PRNUSPoseida Therapeutics Provides Updates and Financial Results..

Your Recent History

Delayed Upgrade Clock